Literature DB >> 6275020

Effect of 2-deoxy-D-glucose on cytomegalovirus-induced DNA synthesis in human fibroblasts.

K D Radsak, D Weder.   

Abstract

2-Deoxy-D-glucose (dGlc) was found to selectively inhibit virus DNA synthesis in human embryonic lung cells infected with human cytomegalovirus (HCMV). The effective concentration of dGlc was approx. 10-fold higher in culture medium containing glucose instead of sodium pyruvate. This inhibitory action of dGlc was fully reversible following replacement of the inhibitor medium by fresh medium after a 48 h treatment of infected cells. Virus DNA synthesis could be selectively inhibited by addition of dGlc even after initiation of HCMV DNA replication. In contrast, virus DNA synthesis in herpes simplex virus-infected cells was insensitive to dGlc. The drug was found to deplete HCMV-infected cells of uridine triphosphate and caused a progressive reduction of uridine incorporation into RNA. To substantiate a possible interference by dGlc with the expression and/or function of virus-induced, chromatin-associated factors essential for virus DNA replication, DNA synthesis of chromatin preparations from dGlc-treated, HCMV-infected cells was analysed. In contrast to preparations of untreated or phosphonoacetic acid (PAA)-treated, HCMV-infected cells, those of dGlc-treated cells lacked significant in vitro DNA-synthesizing activity; virus DNA was not synthesized by these preparations. Tunicamycin in the presence of low concentrations of dimethyl sulphoxide was also found to be effective in abolishing HCMV-induced DNA replication. It is thus suggested that dGlc interferes with the function of an 'early' chromatin-associated glycoprotein essential for virus DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275020     DOI: 10.1099/0022-1317-57-1-33

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Vaccinia virus requires glutamine but not glucose for efficient replication.

Authors:  Krystal A Fontaine; Roman Camarda; Michael Lagunoff
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

Review 2.  Specific targets for antiviral drugs.

Authors:  E De Clercq
Journal:  Biochem J       Date:  1982-07-01       Impact factor: 3.857

3.  Microtubular reaction in human fibroblasts infected by cytomegalovirus. Brief report.

Authors:  G Pfeiffer; D Willutzki; D Weder; B Becker; K Radsak
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

4.  Effect of DNA polymerase inhibitors on the replication of human cytomegalovirus. Brief report.

Authors:  E Gönczöl; S A Plotkin
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

5.  Inhibition of calmodulin-dependent kinase kinase blocks human cytomegalovirus-induced glycolytic activation and severely attenuates production of viral progeny.

Authors:  Jessica McArdle; Xenia L Schafer; Joshua Munger
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

6.  Dengue virus induces and requires glycolysis for optimal replication.

Authors:  Krystal A Fontaine; Erica L Sanchez; Roman Camarda; Michael Lagunoff
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

7.  Distinction of viral and host-derived glycopolypeptides induced by "early" functions of human cytomegalovirus.

Authors:  K Radsak; I Mertensmaier; C Kaiser; C Wagner
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

8.  HCMV targets the metabolic stress response through activation of AMPK whose activity is important for viral replication.

Authors:  Jessica McArdle; Nathaniel J Moorman; Joshua Munger
Journal:  PLoS Pathog       Date:  2012-01-26       Impact factor: 6.823

Review 9.  Infection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infection.

Authors:  Konstantinos Kotzamanis; Ana Angulo; Peter Ghazal
Journal:  Med Microbiol Immunol       Date:  2015-03-24       Impact factor: 3.402

10.  The Human Cytomegalovirus UL38 protein drives mTOR-independent metabolic flux reprogramming by inhibiting TSC2.

Authors:  Irene Rodríguez-Sánchez; Xenia L Schafer; Morgan Monaghan; Joshua Munger
Journal:  PLoS Pathog       Date:  2019-01-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.